成人ICU患者输注红细胞储存时间较短与较长的效果:系统评价、Meta分析与试验序贯分析
该系统评价与Meta分析纳入7项随机临床试验、共18283例成人ICU患者,比较输注较新鲜与较陈旧(或标准发放)红细胞的效果。较新鲜与较陈旧红细胞在死亡(RR 1.04,95%CI 0.97-1.11;7349例)、不良事件(RR 1.26,95%CI 0.76-2.09;7332例)及输血后感染(RR 1.07,95%CI 0.96-1.20;7332例)上均无显著差异。纳入高偏倚风险试验后结果不变,试验序贯分析证实结果,且死亡率在20%相对风险变化时达到所需信息量。结论认为可排除红细胞储存时间对死亡具有临床意义的影响,试验序贯分析可排除10%相对风险变化。
要点
- 成人ICU患者输注较新鲜与较陈旧红细胞在死亡上无显著差异:RR 1.04,95%CI 0.97-1.11(7349例)。
- 不良事件无显著差异:RR 1.26,95%CI 0.76-2.09(7332例)。
- 输血后感染无显著差异:RR 1.07,95%CI 0.96-1.20(7332例)。
- 试验序贯分析可排除10%相对风险变化,死亡率在20%相对风险变化时达到所需信息量。
- 纳入高偏倚风险试验后结果不变,7项试验中2项(7504例)为低偏倚风险。
适用人群与场景
- 成人ICU患者,接受红细胞输注
研究设计与关键结果
- 系统评价与Meta分析纳入7项随机临床试验,共18283例成人ICU患者,比较输注较新鲜与较陈旧(或标准发放)红细胞。
- 死亡:RR 1.04,95%CI 0.97-1.11(7349例),试验序贯分析校正CI 0.93-1.15。
- 不良事件:RR 1.26,95%CI 0.76-2.09(7332例),试验序贯分析校正CI 0.16-9.87。
- 输血后感染:RR 1.07,95%CI 0.96-1.20(7332例),试验序贯分析校正CI 0.90-1.27。
- 7项试验中2项(7504例)为低偏倚风险;纳入高偏倚风险试验后结果不变。
- 试验序贯分析证实结果,死亡率在20%相对风险变化时达到所需信息量;可排除10%相对风险变化。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析及试验序贯分析,纳入随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为可排除红细胞储存时间对成人ICU输血患者死亡具有临床意义的影响,试验序贯分析可排除10%相对风险变化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Patients in the intensive care unit (ICU) are often transfused with red blood cells (RBC). During storage, the RBCs and storage medium undergo changes, which may have clinical consequences. Several trials now have assessed these consequences, and we reviewed the present evidence on the effects of shorter versus longer storage time of transfused RBCs on outcomes in ICU patients.
METHODS: We conducted a systematic review with meta-analyses and trial sequential analyses (TSA) of randomised clinical trials including adult ICU patients transfused with fresher versus older or standard issue blood.
RESULTS: We included seven trials with a total of 18,283 randomised ICU patients; two trials of 7504 patients were judged to have low risk of bias. We observed no effects of fresher versus older blood on death (relative risk 1.04, 95% confidence interval (CI) 0.97-1.11; 7349 patients; TSA-adjusted CI 0.93-1.15), adverse events (1.26, 0.76-2.09; 7332 patients; TSA-adjusted CI 0.16-9.87) or post-transfusion infections (1.07, 0.96-1.20; 7332 patients; TSA-adjusted CI 0.90-1.27). The results were unchanged by including trials with high risk of bias. TSA confirmed the results and the required information size was reached for mortality for a relative risk change of 20%.
CONCLUSIONS: We may be able to reject a clinically meaningful effect of RBC storage time on mortality in transfused adult ICU patients as our trial sequential analyses reject a 10% relative risk change in death when comparing fresher versus older blood for transfusion.
参考来源
- Rygård SL, Jonsson AB, Madsen MB, et al. Effects of shorter versus longer storage time of transfused red blood cells in adult ICU patients: a systematic review with meta-analysis and Trial Sequential Analysis. Intensive Care Med. 2018. PMID: 29372291. doi:10.1007/s00134-018-5069-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。